RxDoctor Payments Data

Sula Gillespie

Pediatrics · Birmingham, ALNPI 1013257476

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $14,367 of the $19,151 with a category attached, or 75.0%. Neurelis, Inc. accounts for 81.4% of it on its own, with 9 other manufacturers making up the rest. Reporting peaked in 2022 at $8,172 and has fallen 58.2% since, to $3,413 in 2025. Among pediatrics clinicians in AL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$19,151in general payments, 2019–2025

Across 191 payments — averaging $100.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Neurelis, Inc.$16K
  • UCB, Inc.$1K
  • Livanova USA, Inc.$1K
  • Jazz Pharmaceuticals Inc.$494
  • SK Life Science, Inc.$117
  • Immedica Pharma US, Inc.$60
  • plus $94 from 4 others

What the payments were for

  • Consulting fees$3752%
  • Speaking & faculty fees$14,36775%
  • Travel & lodging$1,0095%
  • Food & beverage$3,28317%
  • Education$1171%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$19,151 in reported general payments places this provider in the 95th percentile of 908 pediatrics providers in Alabama.

See all pediatrics providers in Alabama

Other pediatrics in Birmingham

See the full list for Alabama

Where these figures come from

Is this you, or does something look wrong? →